Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013
Theodore K. Marras(University of Toronto), Frances Jamieson(University of Toronto), Alex Marchand‐Austin(Public Health Ontario), Michael A. Campitelli(Mount Sinai Hospital), Sarah K. Brode(University Health Network), Hannah Chung, Andrea S. Gershon(University of Toronto), Hong Lu(Ontario Institute for Cancer Research), Jeffrey C. Kwong(University Health Network), Kevin Winthrop(Oregon Health & Science University)
Cited by 92
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
|New England Journal of Medicine|2018|1.2k
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
|European Respiratory Journal|2020|876
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
|Clinical Infectious Diseases|2020|828